Harvard Bioscience (HBIO) Operating Income Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 47.95% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -75.72% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -26.09% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 17.25% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 65.51% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -116.77% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 8.28% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.79% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 97.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.64% |
| Dec 31, 2025 | 916.09% |
| Sep 30, 2025 | 110.51% |
| Jun 30, 2025 | 60.42% |
| Mar 31, 2025 | -2,079.38% |
| Dec 31, 2024 | 275.52% |
| Sep 30, 2024 | -100.86% |
| Jun 30, 2024 | -359.92% |
| Mar 31, 2024 | -230.30% |
| Dec 31, 2023 | -147.24% |
| Sep 30, 2023 | 75.20% |
| Jun 30, 2023 | -80.09% |
| Mar 31, 2023 | 126.06% |
| Dec 31, 2022 | 167.75% |
| Sep 30, 2022 | -786.50% |
| Jun 30, 2022 | 6,793.10% |
| Mar 31, 2022 | -2,708.37% |
| Dec 31, 2021 | 69.22% |
| Sep 30, 2021 | 201.10% |
| Jun 30, 2021 | -89.57% |